BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, Quartier E, Schuit F, Urbain D, Kumar U. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology. 2001;121:915-930. [PMID: 11606505 DOI: 10.1053/gast.2001.27971] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang YY, Tsai TH, Huang YT, Lee TY, Chan CC, Lee KC, Lin HC. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats. Hepatology. 2012;55:1540-1550. [PMID: 22183953 DOI: 10.1002/hep.25534] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
2 Reynaert H, van rossen E, Uyama N, Chatterjee N, Kumar U, Urbain D, Geerts A. Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats. Liver Int 2007;27:825-31. [DOI: 10.1111/j.1478-3231.2007.01503.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Troisi RI, Vanlander A, Giglio MC, Van Limmen J, Scudeller L, Heyse B, De Baerdemaeker L, Croo A, Voet D, Praet M, Hoorens A, Antoniali G, Codarin E, Tell G, Reynaert H, Colle I, Sainz-barriga M. Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial. Annals of Surgery 2019;269:1025-33. [DOI: 10.1097/sla.0000000000003062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
4 XiaoMing Z, Xi Z, Fang S, Jilin Z. Specific changes of somatostatin mRNA expression in the frontal cortex and hippocampus of diabetic rats. J Anat 2004;204:221-5. [PMID: 15032912 DOI: 10.1111/j.0021-8782.2004.00273.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
5 Liu J, Peng L, Yang J, Wang M, Xu S, Liu J, Han P, He J, Tian D, Zhou Q. Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats. Dig Dis Sci. 2015;60:2019-2029. [PMID: 25724163 DOI: 10.1007/s10620-015-3544-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 2002;50:571-581. [PMID: 11889082 DOI: 10.1136/gut.50.4.571] [Cited by in Crossref: 194] [Cited by in F6Publishing: 171] [Article Influence: 10.2] [Reference Citation Analysis]
7 Vanheule E, Geerts AM, Reynaert H, Van Vlierberghe H, Geerts A, De Vos M, Colle I. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int. 2008;28:107-116. [PMID: 18173562 DOI: 10.1111/j.1478-3231.2007.01629.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bai J, Liu X, Le Goff L, Gargala G, François A, Ballet JJ, Ducrotte P, Favennec L, Towledahong L. Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum. PLoS One 2018;13:e0194058. [PMID: 29522573 DOI: 10.1371/journal.pone.0194058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cervia D, Zizzari P, Pavan B, Schuepbach E, Langenegger D, Hoyer D, Biondi C, Epelbaum J, Bagnoli P. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1–sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology 2003;44:672-85. [DOI: 10.1016/s0028-3908(03)00031-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lu YY, Gao JH, Zhao C, Wen SL, Tang CW, Wang YF. Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression. Sci Rep 2018;8:11033. [PMID: 30038293 DOI: 10.1038/s41598-018-29349-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Soon RK, Yee HF. Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis. 2008;12:791-803, viii. [PMID: 18984467 DOI: 10.1016/j.cld.2008.07.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
12 Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005;25:808-16. [PMID: 15998432 DOI: 10.1111/j.1478-3231.2005.01057.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
13 Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, Lee TK, Tsui SH, Ng IO, Zhang ZW. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg. 2003;237:256-264. [PMID: 12560784 DOI: 10.1097/01.sla.0000048976.11824.67] [Cited by in Crossref: 123] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
14 Liu QH, Li DG, Huang X, Zong CH, Xu QF, Lu HM. Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model. World J Gastroenterol 2004;10:1315-20. [PMID: 15112349 DOI: 10.3748/wjg.v10.i9.1315] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
15 Song SH, Leng XS, Li T, Qin ZZ, Peng JR, Zhao L, Wei YH, Yu X. Expression of subtypes of somatostatin receptors in hepatic stellate cells. World J Gastroenterol 2004;10:1663-5. [PMID: 15162546 DOI: 10.3748/wjg.v10.i11.1663] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
16 Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol. 2003;38:564-572. [PMID: 12713866 DOI: 10.1016/s0168-8278(03)00051-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
17 Borbath I, Leclercq IA, Sempoux C, Abarca-quinones J, Desaeger C, Horsmans Y. Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats. Chemico-Biological Interactions 2010;183:238-48. [DOI: 10.1016/j.cbi.2009.10.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
18 Dufourny L, Delmas O, Teixeira-gomes A, Decourt C, Sliwowska JH. Neuroanatomical connections between kisspeptin neurones and somatostatin neurones in the female and male rat hypothalamus: A possible involvement of SSTR1 in kisspeptin release. J Neuroendocrinol 2018;30:e12593. [DOI: 10.1111/jne.12593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Samonakis DN, Triantos CK, Thalheimer U, Patch DW, Burroughs AK. Management of portal hypertension. Postgrad Med J. 2004;80:634-641. [PMID: 15537846 DOI: 10.1136/pgmj.2004.020446] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
20 Reynaert H, Urbain D, Geerts A. Regulation of sinusoidal perfusion in portal hypertension. Anat Rec (Hoboken). 2008;291:693-698. [PMID: 18484616 DOI: 10.1002/ar.20669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
21 Reynaert H, Geerts A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther. 2003;18:375-386. [PMID: 12940922 DOI: 10.1046/j.1365-2036.2003.01657.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
22 Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. Regul Pept. 2014;188:5-12. [PMID: 24291170 DOI: 10.1016/j.regpep.2013.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Xu X, Man K, Zheng SS, Liang TB, Lee TK, Ng KT, Fan ST, Lo CM. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transpl. 2006;12:621-627. [PMID: 16555322 DOI: 10.1002/lt.20630] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
24 Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int 2005;25:1079-90. [PMID: 16343056 DOI: 10.1111/j.1478-3231.2005.01163.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 5.5] [Reference Citation Analysis]
25 Ayabe S, Murata T, Maruyama T, Hori M, Ozaki H. Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors. Br J Pharmacol 2009;156:835-45. [PMID: 19239477 DOI: 10.1111/j.1476-5381.2008.00051.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 Pan Q, Li DG, Lu HM, Lu LY, Wang YQ, Xu QF. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World J Gastroenterol 2004;10:1015-8. [PMID: 15052685 DOI: 10.3748/wjg.v10.i7.1015] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
27 Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 2002;35:1305-12. [PMID: 12029614 DOI: 10.1053/jhep.2002.33469] [Cited by in Crossref: 72] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
28 Jung Y, Oh SH, Zheng D, Shupe TD, Witek RP, Petersen BE. A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells. Lab Invest. 2006;86:477-489. [PMID: 16534498 DOI: 10.1038/labinvest.3700410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
29 Seo YS, Shah VH. Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol 2011;1:87-93. [PMID: 25755320 DOI: 10.1016/S0973-6883(11)60127-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
30 Borbath I, Leclercq IA, Abarca-Quinones J, Desaeger C, Lebrun V, Moulin P, Sempoux C, Horsmans Y. Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide. Cancer Sci 2007;98:1831-9. [PMID: 17900309 DOI: 10.1111/j.1349-7006.2007.00626.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
31 Reynaert H, Rombouts K, Vandermonde A, Urbain D, Kumar U, Bioulac-Sage P, Pinzani M, Rosenbaum J, Geerts A. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut. 2004;53:1180-1189. [PMID: 15247189 DOI: 10.1136/gut.2003.036053] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
32 Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Aliment Pharmacol Ther. 2007;26:1479-1487. [PMID: 17919272 DOI: 10.1111/j.1365-2036.2007.03539.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
33 Reinehr R, Fischer R, Häussinger D. Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells. Hepatology 2002;36:861-73. [PMID: 12297833 DOI: 10.1053/jhep.2002.35623] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
34 Reynaert H, Rombouts K, Jia Y, Urbain D, Chatterjee N, Uyama N, Geerts A. Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol. 2005;146:77-88. [PMID: 15980876 DOI: 10.1038/sj.bjp.0706298] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
35 Hessheimer AJ, Martínez de la Maza L, Adel Al Shwely F, Espinoza AS, Ausania F, Fondevila C. Somatostatin and the "Small-For-Size" Liver. Int J Mol Sci 2019;20:E2512. [PMID: 31121844 DOI: 10.3390/ijms20102512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
36 Colucci R, Blandizzi C, Ghisu N, Florio T, Del Tacca M. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation. Br J Pharmacol. 2008;155:198-209. [PMID: 18587421 DOI: 10.1038/bjp.2008.268] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
37 Adams JM, Low MJ. Gene expression profiling reveals a possible role for somatostatin in the innate immune response of the liver. Genom Data 2015;5:42-5. [PMID: 26056631 DOI: 10.1016/j.gdata.2015.04.029] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Liu Z, van Grunsven LA, Van Rossen E, Schroyen B, Timmermans JP, Geerts A, Reynaert H. Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol. 2010;159:304-315. [PMID: 20039876 DOI: 10.1111/j.1476-5381.2009.00477.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
39 Shah VH, Kamath PS. Portal Hypertension and Gastrointestinal Bleeding. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1489-1516.e5. [DOI: 10.1016/b978-1-4160-6189-2.00090-1] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
40 Rombouts K, Knittel T, Machesky L, Braet F, Wielant A, Hellemans K, De Bleser P, Gelman I, Ramadori G, Geerts A. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. Journal of Hepatology 2002;37:788-96. [DOI: 10.1016/s0168-8278(02)00275-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
41 Uyama N, Geerts A, Reynaert H. Neural connections between the hypothalamus and the liver. Anat Rec 2004;280A:808-20. [DOI: 10.1002/ar.a.20086] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 6.9] [Reference Citation Analysis]
42 Anthony BJ, Ramm GA, McManus DP. Role of resident liver cells in the pathogenesis of schistosomiasis. Trends Parasitol 2012;28:572-9. [PMID: 23099112 DOI: 10.1016/j.pt.2012.09.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
43 Chatterjee S, Mbaye A, De Man JG, Van Marck EA. Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis? Trends Parasitol 2002;18:295-8. [PMID: 12379948 DOI: 10.1016/s1471-4922(02)02294-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
44 Geerts A, Pekny M. Hepatic stellate cells and astrocytes: similarities and differences. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 87-111. [DOI: 10.1007/1-4020-4456-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Mela M, Mancuso A, Burroughs A. Drug treatment for portal hypertension. Annals of Hepatology 2002;1:102-20. [DOI: 10.1016/s1665-2681(19)32169-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Rockey DC. Vascular mediators in the injured liver. Hepatology. 2003;37:4-12. [PMID: 12500181 DOI: 10.1053/jhep.2003.50044] [Cited by in Crossref: 124] [Cited by in F6Publishing: 103] [Article Influence: 6.9] [Reference Citation Analysis]
47 Hessheimer AJ, Escobar B, Muñoz J, Flores E, Gracia-sancho J, Taurá P, Fuster J, Rimola A, García-valdecasas JC, Fondevila C. Somatostatin Therapy Protects Porcine Livers in Small-for-Size Liver Transplantation: Somatostatin Therapy in SFSS. American Journal of Transplantation 2014;14:1806-16. [DOI: 10.1111/ajt.12758] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]